Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2023 May 1;32(5):659–665. doi: 10.1158/1055-9965.EPI-22-1038

Figure 4:

Figure 4:

Proportion of metastatic prostate cancer (MPC) prevalence in 2018 that is diagnosed de novo metastatic by age group and race. MPC prevalence calculated assuming equal de novo and recurrent survival.